Please login to the form below

Not currently logged in
Email:
Password:

EUnetHTA

This page shows the latest EUnetHTA news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 4 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • EU cross-border healthcare EU cross-border healthcare

    Furthermore, to make more rapid and transparent approval decisions around this, national health authorities could draw on existing joint Health Technology Assessment initiatives, such as EUnetHTA.

  • Taking a strategic approach Taking a strategic approach

    Whether the European Network of Health Technology Assessment (EUnetHTA) - set up to create an effective and sustainable network for HTA across Europe - could fulfil this role remains to be seen. ... Nonetheless, EUnetHTA has been collaborating with the

  • EU gives boost to its network of HTA bodies EU gives boost to its network of HTA bodies

    Aims of EUnetHTA:. Supporting efficient production and use of HTA in countries across Europe. ... Main functions of EUnetHTA are to:. Be a contact point for the HTA community in Europe .

  • Interview: Beate Wieseler, IQWIG Interview: Beate Wieseler, IQWIG

    recent plan by the Agency and the HTA body EUnetHTA to work together on making sure that data required by the EMA in its regulatory process aligns with market access requirements

  • NICE’s International Footprint NICE’s International Footprint

    In Europe this takes the form of EUnetHTA, of which NICE itself is a member.

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...